Why majority of heart failure with preserved ejection fraction randomized controlled trials fail? Part: I

Why majority of heart failure with preserved ejection fraction randomized controlled trials fail? Part: I

Today, heart failure with preserved ejection fraction (HFpEF) remains one of the toughest Gordian knots in cardiovascular medicine with no visible effective and acceptable therapies. Owing to the complexity, urgency, and gravity of the problem of HFpEF, the present article has been divided into two...

Full description

Bibliographic Details
Main Authors: Satyanarayana Upadhyayula, Ravi R Kasliwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Clinical and Preventive Cardiology
Subjects:
Catheter ablation
atrial fibrillation
heart failure with preserved ejection fraction
heart failure with reduced ejection fraction
iron repletion
aldosterone antagonist
Online Access:http://www.jcpconline.org/article.asp?issn=2250-3528;year=2018;volume=7;issue=3;spage=120;epage=126;aulast=Upadhyayula

Internet

http://www.jcpconline.org/article.asp?issn=2250-3528;year=2018;volume=7;issue=3;spage=120;epage=126;aulast=Upadhyayula

Similar Items